The big banks will lose significant market share in commercial lending over the coming years, and may consolidate the emerging players. Partly due to them being so hard to deal with. Great opportunity for HUM. Great opportunity for PE too.
- Forums
- ASX - By Stock
- HUM
- Ann: Change of Director's Interest Notice - A Abercrombie
Ann: Change of Director's Interest Notice - A Abercrombie, page-14
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HUM (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
0.020(4.44%) |
Mkt cap ! $230.9M |
Open | High | Low | Value | Volume |
45.0¢ | 47.0¢ | 45.0¢ | $203.3K | 443.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24990 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 28966 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24990 | 0.465 |
2 | 63000 | 0.460 |
2 | 74629 | 0.455 |
1 | 20001 | 0.450 |
1 | 44479 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 28966 | 4 |
0.475 | 14000 | 2 |
0.480 | 93369 | 3 |
0.485 | 20500 | 1 |
0.490 | 14039 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
HUM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online